Assessment of the immune system in 55 Iranian patients with vitiligo
Shokrollah Farrokhi(École Normale Supérieure de Bouzareah Alger), Nima Rezaei(Education and Research Network), M K Noohpisheh, Rasool Tahmasbi, Mohammad Hojjat‐Farsangi(Karolinska University Hospital)
Journal of the European Academy of Dermatology and Venereology
August 2, 2005
Cited by 36
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Combined immunodeficiency and Epstein-Barr virus–induced B cell malignancy in humans with inherited CD70 deficiency
|The Journal of Experimental Medicine|2016|153